Seizert Capital Partners’s Medtronic MDT Stock Holding History

Seizert Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,342	Closed	-$474K	–	191
2017 Q2	$474K	Hold	5,342	–	–	0.02%	161
2017 Q1	$430K	Sell	5,342 -1,158	-18%	-$90.5K	0.02%	174
2016 Q4	$463K	Hold	6,500	–	–	0.02%	175
2016 Q3	$562K	Sell	6,500 -200	-3%	-$17.4K	0.02%	154
2016 Q2	$581K	Hold	6,700	–	–	0.02%	151
2016 Q1	$502K	Hold	6,700	–	–	0.02%	168
2015 Q4	$515K	Hold	6,700	–	–	0.02%	171
2015 Q3	$448K	Sell	6,700 -50	-0.7%	-$3.68K	0.01%	166
2015 Q2	$500K	Hold	6,750	–	–	0.01%	172
2015 Q1	$526K	Buy	6,750 +3,050	+82%	+$231K	0.01%	164
2014 Q4	$267K	Hold	3,700	–	–	0.01%	192
2014 Q3	$229K	Hold	3,700	–	–	﹤0.01%	191
2014 Q2	$236K	Hold	3,700	–	–	﹤0.01%	190
2014 Q1	$228K	Sell	3,700 -1,710	-32%	-$99.6K	0.01%	192
2013 Q4	$310K	Hold	5,410	–	–	0.01%	174
2013 Q3	$288K	Hold	5,410	–	–	0.01%	171
2013 Q2	$278K	Buy	+5,410	New	+$267K	0.01%	175

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Seizert Capital Partners's MDT Position: Q3 2017 in Review

Seizert Capital Partners sold out of Medtronic (MDT) in Q3 2017, closing a stake of 5,342 shares — an estimated $474K sold.

Seizert Capital Partners first reported a position in MDT in Q2 2013 and held it in 17 quarters. The position peaked at $581K in Q2 2016. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

Seizert Capital Partners reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
Seizert Capital Partners sold 5,342 Medtronic shares in Q3 2017, an estimated $474K.
Seizert Capital Partners first reported a position in Medtronic in Q2 2013 and held it in 17 quarters.
Seizert Capital Partners's Medtronic position peaked at $581K in Q2 2016.
1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Seizert Capital Partners's 13F filing for Q3 2017, filed 31 Oct 2017.